“◐저녁때◑┏www. yeotop6 , com ┒신답오피Ⅰ신답스파✜신답오피✁신답립카페★신답건마☫신답안마✎신답OP”的搜索结果，显示 281-290 项，共有 11903 项

1. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   1. Create a registry of patients having or at risk for cancer of the liver or bile ducts (also known as hepatocellular carcinoma or cholangiocarcinoma), or ...

2. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   This study is being done to: 1. Create a registry of patients having or at risk for cancer of the liver or bile ducts (also known as hepatocellular carcinoma or ...

3. 血液科- 临床试验- 妙佑医疗国际

   Patients randomized to B+R will receive 6 cycles of treatment consisting of a rituximab infusion (Cycle 1: 375 mg/m2; Cycles 2-6: 500 mg/m2) on Day 1 and ...

4. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Rochester, Minn. The purpose of this study is to estimate the efficacy of LUTATHERA treatment in patients with recurrent grade 1 meningioma as measured by 6- ...

5. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   This study is being done to: 1. Create a registry of patients having or at risk for cancer of the liver or bile ducts (also known as hepatocellular carcinoma or ...

6. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   This study is being done to: 1. Create a registry of patients having or at risk for cancer of the liver or bile ducts (also known as hepatocellular carcinoma or ...

7. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   This phase I trial evaluates the safety, effectiveness, and best dose of onvansertib for the treatment of patients with chronic myelomonocytic leukemia that ...

8. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   1. Create a registry of patients having or at risk for cancer of the liver or bile ducts (also known as hepatocellular carcinoma or cholangiocarcinoma), or ...

9. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   The purpose of this study is to compare the effect of adding nivolumab to the usual chemotherapy (cisplatin or carboplatin with gemcitabine) versus the ...

10. 神经科- 临床试验- 妙佑医疗国际

    The purpose of this study is to collect adult human blood, cerebrospinal fluid, brain, and spine tissues/fluids at time of surgery in order to conduct ...